High-dose quetiapine and therapeutic monitoring

0 avis

High-dose quetiapine and therapeutic monitoring

Archive ouverte

Javelot, Hervé | Rangoni, Francis | Weiner, Luisa | Michel, Bruno

Edité par CCSD -

Quetiapine is an atypical antipsychotic with a good safety profile permitting its administration beyond the maximum dose of 800 mg/day. We report the case of a patient with a resistant schizophrenia treated with high doses of quetiapine (up to 2000 mg/day) combined with drug monitoring and with favourable therapeutic response and tolerance.

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Benefits and Limits of Risperidone-Methylphenidate Combination in Child Psychiatry: 3 Cases

Archive ouverte | Javelot, Hervé | CCSD

International audience. Methylphenidate remains the first choice treatment for attention deficit hyperactivity disorder (ADHD), but comorbid forms with Disruptive Behaviour Disorders (DBD) are undertreated.Methylphe...

A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution

Archive ouverte | Heitzmann, Edwige | CCSD

Aripiprazole is reported to be a good clinical safety profile antipsychotic. However, recent data suggest that the risk of tardive dyskinesia could be higher than initially thought. We report the case of aripiprazole-induced tardi...

About a case of hypersalivation secondary to the substitution of a chronic treatment with clonazepam. À propos d’un cas d’hypersalivation secondaire à la substitution d’un traitement chronique par clonazépam

Archive ouverte | Berard, Marie | CCSD

International audience. Clozapine-induced hypersalivation is usually related to chronic exposures and/or a dose increase. Wereport an atypical case of a patient whose hypersalivation is due to a reduction in dosage ...

Chargement des enrichissements...